Ovid Therapeutics Inc. · Brief

Next report

9 days

Nov 10 · before openest.Q3 FY26

Expected move

±32.1%implied · report alone

1.733.35

straddle ±33.5%

spot 2.54exp Nov 20ATM strike 2.5ATM straddle 1.00IV 209%

Oct 30 closereport share · term structurethin chain

Expected move

No reported quarters.

Nov 10 report · est.

Bull2 of 3

7disclosed supplier and customer ties in SEC filingsSEC filings

131managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

14managers whose positions together make up four fifths of reported value13F · Jun 30 '26

5 of 20of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

OVID report session

No linked exposure.

Oct 27impliedImplied move: ±41.4% into Nov 10 earnings (Oct 27 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.